Bronchitis Clinical Trial
Official title:
Non-interventional Study on the Quality of Life Before and After Intake of Sinolpan® (Forte) in Inflammatory Diseases of the Respiratory Tract - an Anonymous Patient Survey
This non-interventional study investigates the Quality of Life of patients suffering from rhinosinusitis. Patients who seek advice in a pharmacy and choose to intake Sinolpan® or Sinolpan® forte or to use nasally applied α-sympathomimetics can participate in this anonymous patient survey.
Within the scope of this non-interventional observational study, the quality of life of rhinosinusitis patients under self-medication with the 1,8 - cineole preparation Sinolpan® or Sinolpan® forte (Sinolpan® group) or with a nasally applied α-sympathomimetic (control group) is investigated during conditions of daily life. Patients who seek advice from a pharmacy regarding the treatment of their symptoms and who choose Sinolpan® (forte) or a nasal α-sympathomimetic can participate in this study and are asked to complete a questionnaire before and after the treatment. For organizational reasons, the recruitment of patients for the Sinolpan® group (planned number of patients: 500) or the control group (planned number of patients: 50) is conducted in different pharmacies. The primary objective of this anonymous data collection is to assess the quality of life in patients with rhinosinusitis. The German version of the Rhinosinusitis Quality of Life questionnaire, which was only recently validated in a doctoral thesis, is used for this purpose. Additionally, for patients in the Sinolpan® group who also suffer from bronchitis, the bronchitis severity score is determined. In addition, data on side effects and tolerability of the treatment as well as on patients' satisfaction are collected. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04016051 -
Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections
|
Phase 3 | |
| Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
| Recruiting |
NCT02913365 -
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
|
N/A | |
| Completed |
NCT00350987 -
Procalcitonin Guided Antibiotic Therapy and Hospitalisation in Patients With Lower Respiratory Tract Infections: The "ProHOSP" Study
|
N/A | |
| Completed |
NCT01033799 -
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
|
N/A | |
| Completed |
NCT00250679 -
Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
| Completed |
NCT00371527 -
Effect of Ipratropium on Acute Bronchitis in Subjects Without Underlying Lung Disease
|
N/A | |
| Completed |
NCT00042718 -
A Study of the Effectiveness and Safety of High Dose, Short-course Levofloxacin in the Treatment of Acute Bacterial Exacerbation (Worsening) of Chronic Bronchitis.
|
Phase 3 | |
| Completed |
NCT02902640 -
A Non-Interventional Safety Study of Balsamic Bactrim
|
N/A | |
| Completed |
NCT02879981 -
A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis
|
||
| Recruiting |
NCT04144699 -
Clinical Validation of Omron WheezeScan
|
||
| Recruiting |
NCT03320382 -
Multiple Breath Washout, a Clinimetric Dataset
|
||
| Recruiting |
NCT04415827 -
Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases
|
N/A | |
| Completed |
NCT01354938 -
Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Patients With Acute Exacerbation of Chronic Bronchitis
|
N/A | |
| Completed |
NCT03535558 -
Fluoroquinolone Associated Disability
|
||
| Recruiting |
NCT05330637 -
Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.
|
||
| Completed |
NCT01240174 -
Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis
|
N/A | |
| Completed |
NCT01108185 -
Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract Infection
|
N/A | |
| Completed |
NCT00011310 -
Cardiopulmonary Effects of Particulate Exposure
|
N/A | |
| Completed |
NCT00415753 -
Procalcitonin as a Marker of Bacterial Pneumonia
|
N/A |